Navigation Links
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
Date:4/2/2008

WELLESLEY HILLS, Mass., April 2, 2008 /PRNewswire/ -- Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced today the completion of the sale of ActivBiotics intellectual property assets for $3.5 million. The assets consisted of 1) Rifalazil, a Phase II antibiotic, 2) a library of novel rifamycin compounds, and 3) a clinical stage superoxide dismutase mimetic (SODm) and a library of SODm small molecules.

Mr. Finn praised the team of ActivBiotics executives who worked closely with him after the assets were assigned to him. He singled out Christo Shalish, MBA, Director of Business Development, Chris Murphy, Ph.D., Director of Pharmacology, and David Rothstein, Ph.D., Senior Director of Preclinical Development.

The sale of the assets was conducted through an Assignment for the Benefit of Creditors. This process entails transference of the assets to a fiduciary who then liquidates them for the benefit of the creditors of the company.

Source and Contact Information

Joseph F. Finn, Jr., CPA, Finn, Warnke & Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481. E-mail: jffinnjr@earthlink.net, phone: 781-237-8840.


'/>"/>
SOURCE Finn, Warnke & Gayton
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis of Cancer
2. ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, on March 14, 2008
3. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
4. ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates
5. Amarin Secures Global Intellectual Property Rights for Lipid Programs
6. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
7. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
8. NIST develops test method for key micromechanical property
9. New property found in ancient mineral lodestone
10. OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNAs, Including Its Phase III Compound Bevasiranib
11. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...and, Oct. 10 /- Twenty of Britain,s m... funds and exhibit their,ideas at the fifth annual...which will be held at One Great George Street, Lon...gether the cream of technology innovators,in elect...otechnology., Six companies will give 10-minute p...
(Date:10/9/2008)...itzerland, October 10 /-, ...ife Sciences Industry, Merck Serono, a division o...that it has been named by Science magazine as a to... industries, ranking number 7 out of the,top 20 em...d that the scientific community has recognized Mer...
(Date:10/9/2008)...s Positive Operating Income Excluding Non-Cash Cha... CardioDynamics (Nasdaq:,CDIC), the innovator and ...hnology, today reported financial results for fisc...rd Quarter 2008 Compared with Third Quarter 2007 ...from $5.6 million -- International sales increase...
(Date:10/9/2008)...ion and NCPA Join Forces to Deliver Patient Care v...ro(SM), RESTON, Va. and WASHINGTON, Oct. 9 /PRNew...macists Association (APhA) Foundation, the creator...in the Asheville Project(R),jointly announced tod...,deliver all of APhA Foundation,s HealthMapRx comm...
Breaking Biology Technology:Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3Merck Serono Named as a Top Employer by Science Magazine 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 3CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 5CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 6Mirixa Corporation and the APhA Foundation Form Partnership 2Mirixa Corporation and the APhA Foundation Form Partnership 3
... More thermostable than AMV RT and M-MLV RT ,... antiviral agents , Highly... Ideal for reverse transcribing t...ntent , Like M-MLV reverse ..., Ambion,s HIV RT synthesizes cDNA from single-str...
... Quantitate gene expression , ... 5 minute cell lysis , ...al for monitoring , siRNA-induc... with TaqMan , Gene Expression ...RT-PCR from lysate , equivalent...
... protects cellular RNA , within...pping. , Whether you are in the... you can use this aqueous, non-toxic Tissu...n Solution from ambient temperatures down to , ...cterization of disease mechanisms using , ...
...nstruction Kit , Prepare...ur , Ideal for siRNA/miRN... Synthesize high specific , ...thern, or in situ hybridization , ... , With the mir Vana miRNA ...
Other Biology Technology:Recombinant HIV Reverse Transcriptase 2Ready for Real-time in 5 Minutes 2Ready for Real-time in 5 Minutes 3Ready for Real-time in 5 Minutes 4Ready for Real-time in 5 Minutes 5Ready for Real-time in 5 Minutes 6Preserve Samples for RNA Expression Microarrays RNAlater Around the World 2Preserve Samples for RNA Expression Microarrays RNAlater Around the World 3Preserve Samples for RNA Expression Microarrays RNAlater Around the World 4Preserve Samples for RNA Expression Microarrays RNAlater Around the World 5Prepare siRNA and miRNA Probes in Just 1 Hour 2Prepare siRNA and miRNA Probes in Just 1 Hour 3
(Date:10/10/2008)...UKEE, MADISON Governor Jim Doyle today announced ...search institutions to advance personalized health...esses diseases. The Wisconsin Genomics Initiative ...field Clinic, Medical College of Wisconsin (MCW), ...lic Health (UWSMPH) and UW-Milwaukee (UWM). , Wi...
(Date:10/10/2008)... Local to Global, will be the focus of the Society... but this single event is just one small step in f...priority around the world and requires immediate a... poor nutrition, hunger and deficiencies. The Soci...embers and the public to get involved and make a d...
(Date:10/9/2008)...ct. 9 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasda...gy and biometrics software,has scheduled a confer...ts,for the third quarter of 2008 on Thursday, Octo...el Tzannes and CFO Rick Moberg will host the,earni...by Thomson and can be accessed on the,Investor Rel...
(Date:10/9/2008)...y-five years, the number of patients with compromi...risk patients such as these require a unique set o...n everything from the etiology and degree of immun...nal status. A new text from ASM Press, Diagnostic ...nes a wide range of approaches and challenges to i...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2World Food Day brings attention to food security around the globe 2Aware Announces Q3 2008 Earnings Conference Call 2Text focuses on diagnosing infections in immunocompromised patients 2Gain a Foothold on Winter Walking Safety 8931 1Marital Status Doesnt Affect Lung Cancer Survival 1121 1Marital Status Doesnt Affect Lung Cancer Survival 1121 2Marital Status Doesnt Affect Lung Cancer Survival 1121 3Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 1Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 2Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 3Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 4Pennsylvania Invests 2412 5 Million to Kick Off Williamsport Hospital Project 8921 1
...n, a University of Iowa anthropologist and his col... a "pygmy-sized" giant panda -- the earliest-known...h China some two million years ago. , The ancestor...anda, says Russell Ciochon, UI professor of anthro...hor of an article published in the June 18-22 onli...
...cumented the link between the way an animal moves ...an of balance, the three semicircular canals of th... article on its research will be published on 26 J... National Academy of Sciences and in the journal,s...June. , "We have shown that there is a fundament...
...ng pathway in cells that is altered by genetic mut...velopment. These new findings show how the mutati...arget for drug therapies to treat the disease. Th...s will be published June 18 in the Public Library ...kinson disease is a degenerative disorder of the c...
...onal reasons, superb starling females appear to st... according to recent Cornell research published in... , The study found that superb starling females (L...ariety of reasons. Some females mate with subordin... need help to raise their chicks. (Superb starling...
Other Biology News:UI anthropologist, colleagues discover remains of earliest giant panda 2Reconstructing the biology of extinct species: A new approach 2Researchers identify protein pathway involved in Parkinson disease development 2CU study reveals why starling females cheat 2
...s Tissue Array (MSTA) slides were designed to stud...nd tissues from multiple species. Tissue slices f...TA slide which can then be treated as a single his...stry, or in situ hybridization. This format all...
WinMelt software is used to predict the melting profile of any DNA sequence up to 3,200 bases, which aids in optimizing placement of primers and GC clamps for mutation detection by denaturing gradien
...ons RNAi Services offer you a full range of soluti...ign parameters, effective synthetic siRNA reagents...uality results from your siRNA experiments. siSolu...ary B-Algo algorithm to define siRNA sequences wit...
...96 and PowerPac basic power supply are used for su...acids in agarose gels. This Model 96 cell includes...ay with fluorescent ruler, and a gel caster. The P... provides output of 10-300 V, 4-400 mA, and 75 W. ...
Biology Products: